drugset / Trial / NCT00160667
A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study will assess efficacy, safety and tolerability of brivaracetam in post-herpetic neuralgia (PHN). Duration of 7 weeks divided into 3 periods with no up-titration, nor down-titration.
Timeline
- Start
- 2004-10-11
- Primary completion
- 2006-01-05
- Completion
- 2006-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivaracetam | Small molecule | 200 mg | Oral |
| Subject | Brivaracetam | Small molecule | 400 mg | Oral |